Articles On Bio-Gene Technology (ASX:BGT)

Bio-Gene Technology (ASX: BGT) has received approval from the Organic Materials Review Institute in the US to list its Qcide natural insecticide as a Botanical Pesticide under the USDA National Organic Program.

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX today − Australian shares are heading for a battering once Friday’s bell rings for trading this morning, with ASX 200 futures pointing to a -1.4% nosedive (around 120 points) after the lengthy U.S. shutdown finally lifted. Listen to...

ASX falls 81 points or 0.92pc by end of trade Utilities and energy sectors the only resistance Financials hit hardest, undercut by inflation numbers ASX returns to September form The ASX 200 is in a snit once again, pulling sharply back i...

ASX rises 0.4pc with eight of 11 sectors higher Materials, major banks lead gains Myer takes an absolute beating Gold bull run continues Everyone’s favourite precious metal is continuing its bull run and dragging the ASX with it. Gold fut...

Good Afternoon and welcome to HotCopper’s Market Close for Tuesday 23rd of September, I’m Jon Davidson. It looks like three straight record sessions in the US has been enough to wake some Aussie investors out of a September slumber. A m...

A tick-targeting insecticide “derived from nature” that has in early stage lab testing shown to be a promising agent with which to kill lyme disease vector Ixodes scapularis, a type of tick; this positive data leading insecticide player Bio...

Bio-Gene Technology (ASX: BGT) has released new data confirming that its lead compound Flavocide delivers strong activity against ticks responsible for spreading Lyme disease in the United States. Presented by Purdue University researchers...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX pares back early gains to lift 0.32pc Healthcare, tech, utilities drive gains Resources sector drags as gold prices slip from highs ASX gets clean bill of health The ASX was looking a little healthier today, adding 0.32% or 28.3 poi...

ASX wobbles into the green today, adding 13.4 points or 0.16pc Gains led by Utilities, Industrials and Tech sectors Financials worst performing sector, down 0.62pc Despite a bit of a rollercoaster of a day, the ASX has settled up just ove...

ASX recovers from early dip to post 0.24pc gain Tech stocks surge with sector up 4pc Energy and Materials weigh on gains, down more than 1pc each An after-hours surge in US tech stocks has lit the Aussie tech sector on fire, rocketing up...

By stockpiling components, the US-focused Impedimed is taking no chances with tariffs Cashed-up Amplia forges ahead with promising pancreatic cancer trial Some biotechs are headed to the well, while others are rolling in the green stuff...

This week’s Bulls N’ Bears Runner of the Week is… Bio-Gene Technology. Their shares surged after scoring US defence grants, while Alterity Therapeutics, Aston Minerals and Canterbury Resources also ran hard.

ASX near record high on inflation drop and rate cut bets Tech stocks rally as rate cut expectations rise Microsoft probes DeepSeek over data breach   The ASX200 put on a solid show today as it rose by 0.75%, closing just shy of its all-ti...

The All Ordinaries Index (ASX: XAO) is up a healthy 1.0% on Wednesday, but one ASX small-cap stock is leaving those gains wanting. The company in question is Bio-Gene Technology Ltd (ASX: BGT), which is focused on developing bio-insecticid...

Bio-Gene Technology (ASX: BGT) has been awarded $3 million in grants by the US Department of Defense to develop insecticide products to protect its workforce from threats posed by disease-carrying species including mosquitoes and ticks. The...

Bio-Gene Technology (ASX:BGT) has received its receipt of contracts from the U.S. Department of Defence to assess BGT’s flagship insecticides. Bio-Gene’s ‘Flavocide‘ will be developed into a wearable product ($1.6 million), while a secon...

ASX jumps on strong banks and jobs report Zip and Tabcorp surge as markets rally Oil prices soar amid supply risks and cold weather   The ASX flexed its muscles today, up 1.38% on the back of strong bank gains and a bit of global risk-on...

ASX set to open higher, driven by easing inflation data in the US US PPI fell short of expectations, boosting hopes for a Fed rate cut Starbucks up 24pc, Nvidia up 7pc, and Avon filed for bankruptcy   The ASX is set to open sharply higher...

Agtech company Bio-Gene Technology (ASX:BGT) has announced the appointment of Roger McPherson as joint company secretary on an interim basis.

Crops for 2023 were underwhelming, but things could turn around in 2024 Select Harvests is expecting good output in 2024 Cobram and Costa Group are also expecting a better year   The global almond market is expected to grow at a CAGR of b...

Agtech development company Bio-Gene Technology (ASX:BGT) has announced it has raised around $1.9 million through a placement and share purchase plan.

Bio-Gene Technology (BGT) secures a new US patent, “significantly” extending coverage of the company’s molecules in the country The patent sits alongside the company’s other US patent controlling all classes of resistant insects and arac...

Bio-Gene Technology (ASX:BGT) has signed a Development and License Agreement with Israel-based STK Bio-Ag Technologies.

The ASX 200 put on a much better show today, with a +0.46% gain at closing time Sectors wise, Materials turned yesterday’s frown upside down Notable performers today: Pilbara Minerals; DXN; Si6 Metals; Strickland Metals   It’s been a much...

Climate change, El Niño, conflict and increasing urbanisation is putting pressure on food security globally Graincorp continues to diversify its business to operate beyond the variations of Australian weather patterns Roots Sustainable Agr...

Agtech company Bio-Gene Technology (ASX:BGT) has announced the allowance of a patent application (17/045,457) by the United States Patent Office.

Food sustainability is becoming a major global problem The future of our climate as a result of unsustainable food production seems bleak Stockhead reached out to ASX-listed Roots Sustainable Agricultural Tech CEO, Boaz Wachtel   Finnish...

The ASX closed out the day flat, thanks to a last-minute selling spree Qantas announces record profit but still won’t give us back the money we gave them during Covid Westar Resources won the Small Caps race, in spite of a 90-minute hobbli...

An afternoon rally has put some lead back in the market’s pencil, closing down 0.08%. Tech stocks and Small Ordinaries drive the wins, with InfoTech up 1.5% for the day. Lithium’s back on the menu, with three big names making some chunky,...

ASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today, adding 0.5% on an otherwise fairly moribund day Voltaic Strategic Resources climbs 188% on pre-assay lithium results at Ti Tree   The ASX h...

The ASX 200 turned Hump Day into Slump Day, dropping 1.1% Goldies shone bright under trying conditions to be up more than 2.6% Greentech Metals went ham on the gains, adding 200% while the rest of the market wept   Things haven’t really i...

Bio-Gene Technology (BGT) has landed a new US patent to expand the protection of its insecticide products The patent relates to the company’s Flavocide product for the control of pesticide-resistant pests and will expire in July 2038...

Ag-tech company Bio-Gene Technology (ASX:BGT) and STK Bio-Ag Technologies have announced binding terms on a new global collaboration.

Bio-Gene Technology (BGT) receives a $446,000 tax rebate from the Australian Taxation Office The refund falls under the Australian Federal Government’s research and development tax incentive The cash was refunded for costs incurred du...

The ASX 200 rose up 0.57% but the ASX XEC slipped -0.08% A solid 8 out of 11 sectors were higher, with Materials leading the way ABS says high participation and low unemployment continues to reflect a tight labour market   The ASX 200 gai...

Bio-Gene Technology (BGT) enters global collaboration with Israel-based STK Bio-Ag Technologies The partnership gives STK non-exclusive development and commercialisation rights for Qcide for crop protection applications It follows a c...

Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million   The...

ASX200 and small caps end about 0.4% down BNPLs come out of hibernation WA1 is finding even more niobium   Local markets failed to launch on Wednesday, unlike the missile strikes early this morning AEDT, which reportedly crossed the borde...

Food prices around the world continue to surge on the back of  a bleak global economic outlook How long will this last and why aren’t food stocks soaring in line with prices?  From transport delays to slowing harvests, the COVID-19 pandem...

XEC rises like a stubborn mule, up 0.5% XJO wobbles, equivocates somehow ends 0.2% higher Galileo Mining (ASX:GAL) gains circa 200%   Choppy trade – oh yes – but with Galileo Mining (ASX:GAL) coming out swinging on Wednesday morning, tha...

German chemical company, BASF, has left Bio-Gene Technology’s (BGT) stored grain pest program Bio-Gene recently announced it successfully completed the nine-month study and the results were reviewed with the parties and a plan was being de...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

XEC falls on Tuesday XJO closes 1.2% lower Carbon Revolution (ASX:CBR) gets Gov backing, shares pop   Another tense morning of selling on the ASX200 has eased off in afternoon trade, although the small cap index will be leaving the barbe...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The preferred, often heroic index of the Australian small cap, The Emerging Companies XEC has shed 2.4% today, to add to the haemorrhaging of the last four weeks. The ASX200 (XJO) has closed just 0.2% lower. If this is a cash rate thing, wh...

The preferred, often heroic index of the Australian small cap, The Emerging Companies XEC has shed 2.4% today, to add to the haemorrhaging of the last four weeks. The ASX200 (XJO) has closed just 0.2% lower. If this is a cash rate thing, wh...

First up, ladies and gents, inflation has spiked way above what the RBA and everyone else was expecting. The headline consumer prices rose 5.1% over the year – consensus was looking at around 4.6% – which frankly would’ve been bad enough bu...

Agtech company Bio-Gene Technology (ASX:BGT) has announced a new licence and development agreement with Clarke Mosquito Control Products.